Year None202320222021202020192018201720162015201420132012 09.02.2021 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 08.10.2021 Iveric Bio to Present at the H.C. Wainwright Ophthalmology Virtual Conference 08.04.2021 Iveric Bio to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2021 08.04.2021 Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results 08.03.2021 Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 07.28.2021 Iveric Bio to Report Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021 07.26.2021 Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule 07.19.2021 Iveric Bio Appoints Christopher Simms as Chief Commercial Officer 07.12.2021 IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock 07.12.2021 IVERIC bio, Inc. Announces Proposed Offering of Common Stock Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last »
